REDUCTION OF CONCOMITANT ORAL METHOTREXATE OR CORTICOSTEROIDS IN COMBINATION TREATMENT WITH ADALIMUMAB DOES NOT AFFECT EFFECTIVENESS IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：1

作者：

Keystone, E. ^{[1
]}

Breedveld, F. ^{[2
]}

Kavanaugh, A. ^{[3
]}

Zhang, Y. ^{[4
]}

Sainsbury, I. ^{[4
]}

Kalabic, J. ^{[5
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] Univ Calif San Diego, La Jolla, CA 92093 USA

[4] AbbVie, N Chicago, IL USA

[5] AbbVie, Ludwigshafen, Germany

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.2389

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0315

引用

收藏

页码：1008 / 1008

页数：1

相关论文

共 2 条

[1] Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safety of Adalimumab from the Randomized Controlled PREMIER Trial with Open-label Extension
Keystone, Edward C.
Breedveld, Ferdinand C.
van der Heijde, Desiree
Landewe, Robert
Florentinus, Stefan
Arulmani, Udayasankar
Liu, Shufang
Kupper, Hartmut
Kavanaugh, Arthur
[J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (01) : 5 - 14
[2] Clinical, Functional, and Radiographic Benefits of Longterm Adalimumab Plus Methotrexate: Final 10-year Data in Longstanding Rheumatoid Arthritis
Keystone, Edward C.
van der Heijde, Desiree
Kavanaugh, Arthur
Kupper, Hartmut
Liu, Shufang
Guerette, Benoit
Mozaffarian, Neelufar
[J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (09) : 1487 - 1497